Print
Veronika Bachanova, MD, PhD
Request Appointment
Blood and Marrow Transplant Clinic
Phillips-Wangensteen Building
Fifth Floor, Clinic 5B
516 Delaware St. SE
Minneapolis, MN 55455
612-273-2800
 

Philosophy of Care:

Treating patients with blood cancers, I have witnessed the unique capability of the donor immune system to eliminate cancer. A growing desire to better understand the underlying process led me to embark on the pathway of an academic hematologist. In my clinical practice, I deeply care about my patients and strive to provide them with the best care and access to the novel drugs and clinical treatments. This includes the development of innovative clinical trials which systematically look for deeper understanding how immune system work in curing leukemia and lymphoma.

Medical Title:

Academic Appointments:

Specialties:

Clinical Interests:

Education:

Board Certifications:

2010, Ernest McCulloch and James Till Award for best basic science article by a new investigator Biology of Blood and Marrow Transplantation

2008, Clinical Investigator CALGB Award and Grant

2007, American Society of Hematology Clinical Research Training Institute workshop award

2007, Young ASCO investigator Award

Bachanova V, Burns LJ, McKenna DH, Curtsinger J, Panoskaltsis-Mortari A, Lindgren BR, Cooley S, Weisdorf D, Miller JS. Allogeneic natural killer cells for refractory lymphoma. Cancer Immunol Immunother. 2010 Aug 3. [Epub ahead of print]

Bachanova V, McCullar V, Lenvik T, Wangen R, Peterson KA, Ankarlo DEM, Panoskaltsis-Mortari A, Wagner JE, Miller JS. Activated Notch supports development of cytokines producing NK cells which are hyporesponsive and fail to acquire NK cells effector function. Biol Blood and Marrow Transplantation. 2009; 15:183-194.

Bachanova V, Defor T, Verneris M, Brunstein C, Weisdorf D. Prolonged survival in adults with acute lymphoblastic leukemia (ALL) following reduced intensity conditioning with cord blood or sibling donor transplantation. Blood. 2009; 113 (13):2902-5.

Bachanova V, Brunstein CG, Burns LJ, Miller JS et al. Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma. Bone Marrow Transplant. 2009; 43(3):237-44.

Bachanova V, Connors JM. How is Hodgkin lymphoma in pregnancy best treated? Hematology Am Soc Hematol Educ Program. 2008; 2008:33-4.

 

 
 Visit Other Fairview Sites 
 
 
(c) 2012 Fairview Health Services. All rights reserved.